EllisLab_'s profile picture. Center for Prostate Disease Research @cpdr_labs @usuhealthsci @wrnmmc_dha @nciccr_gmb #epigenetics #plasticity #immunity #therapy #GUcancers tweets=mine 🇦🇺😷

EllisLab_

@EllisLab_

Center for Prostate Disease Research @cpdr_labs @usuhealthsci @wrnmmc_dha @nciccr_gmb #epigenetics #plasticity #immunity #therapy #GUcancers tweets=mine 🇦🇺😷

EllisLab_ reposted

How can spatial transcriptomics achieve whole-genome coverage while maintaining single-molecule resolution without requiring sequencing?@CellCellPress @YaleMed "Sequencing-free whole-genome spatial transcriptomics at single-molecule resolution" • RAEFISH addresses the…

aipulserx's tweet image. How can spatial transcriptomics achieve whole-genome coverage while maintaining single-molecule resolution without requiring sequencing?@CellCellPress @YaleMed 

"Sequencing-free whole-genome spatial transcriptomics at single-molecule resolution"

• RAEFISH addresses the…

EllisLab_ reposted

Spatial Multiomics (Metabolome➡️ Lipidome➡️ Glycome) on a single 10 µm brain section👹 +Sami Spatial Augmented Multiomics Interface with Small Molecule Pathway Database Direct pixel-to-pixel matching across modalities😎 @RCSunlab @NatureComms 2025 nature.com/articles/s4146…

HaoYin20's tweet image. Spatial Multiomics (Metabolome➡️  Lipidome➡️ Glycome) on a single 10 µm brain section👹

+Sami
 Spatial Augmented Multiomics Interface
with Small Molecule Pathway Database

Direct pixel-to-pixel matching across modalities😎

@RCSunlab @NatureComms 2025
nature.com/articles/s4146…

Some exciting insights coming from our diverse cohorts at the epigenomic single cell level @CPDR_Labs

Scientific Director @EllisLab_ presents our exciting collaborative work with @AtlasXomics on assessing the #spatialepigenetic landscape in #prostatecancer in a robust cohort of diverse localized disease. #TeamScience

CPDR_Labs's tweet image. Scientific Director @EllisLab_ presents our exciting collaborative work with @AtlasXomics on assessing the  #spatialepigenetic landscape in #prostatecancer in a robust cohort of diverse localized disease. #TeamScience


Great work and findings here 👇🏼 Congrats Trudy

Nature research paper: Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer go.nature.com/46rf5BS



Bethesda @CPDR_Labs is waiting 🤓

The Force is strong in these two… From Oz to Memphis on a galactic mission with my Queen - cool sciency stuff, we must do. 💥

LGMartelotto's tweet image. The Force is strong in these two… 

From Oz to Memphis on a galactic mission with my Queen - cool sciency stuff, we must do. 💥


EllisLab_ reposted

We have developed a new workflow to map whole human organs at single-cell resolution, while integrating spatial transcriptomics, proteomics, and metabolomics. We applied this workflow to map precancerous lesions of the fallopian tubes. More here: biorxiv.org/content/10.110…

deniswirtz's tweet image. We have developed a new workflow to map whole human organs at single-cell resolution, while integrating spatial transcriptomics, proteomics, and metabolomics.

We applied this workflow to map precancerous lesions of the fallopian tubes.

More here: biorxiv.org/content/10.110…

EllisLab_ reposted

Are you looking for a postdoctoral position where you will be challenged to dig deep into the post-transcriptional mechanisms of cancer? If so, check out @HsiehLab @fredhutch, we have an opening (careers-fhcrc.icims.com/jobs/30066/pos…)! Website: research.fredhutch.org/hsieh/en.html

HsiehLab's tweet image. Are you looking for a postdoctoral position where you will be challenged to dig deep into the post-transcriptional mechanisms of cancer? If so, check out @HsiehLab @fredhutch, we have an opening (careers-fhcrc.icims.com/jobs/30066/pos…)! Website: research.fredhutch.org/hsieh/en.html

EllisLab_ reposted

Thank you prostate scientist-extraordinaire @JoshLangMD for coming to our @DanaFarber Grand Rounds “Sweeney Lecture @si. Elegant work in CTC at the crossroads of translational research and bioengineering! cc: @DanaFarber_GU @mishabeltran

DrChoueiri's tweet image. Thank you prostate scientist-extraordinaire @JoshLangMD for coming to our @DanaFarber Grand Rounds “Sweeney Lecture @si. Elegant work in CTC at the crossroads of translational research and bioengineering! cc: @DanaFarber_GU @mishabeltran
DrChoueiri's tweet image. Thank you prostate scientist-extraordinaire @JoshLangMD for coming to our @DanaFarber Grand Rounds “Sweeney Lecture @si. Elegant work in CTC at the crossroads of translational research and bioengineering! cc: @DanaFarber_GU @mishabeltran
DrChoueiri's tweet image. Thank you prostate scientist-extraordinaire @JoshLangMD for coming to our @DanaFarber Grand Rounds “Sweeney Lecture @si. Elegant work in CTC at the crossroads of translational research and bioengineering! cc: @DanaFarber_GU @mishabeltran
DrChoueiri's tweet image. Thank you prostate scientist-extraordinaire @JoshLangMD for coming to our @DanaFarber Grand Rounds “Sweeney Lecture @si. Elegant work in CTC at the crossroads of translational research and bioengineering! cc: @DanaFarber_GU @mishabeltran

EllisLab_ reposted

Join our lab for a 4-year funded PhD in #Epigenomics, #SingleCell, & #SpatialBiology! We’re looking for someone with #Bioinformatics / #Biocomputational skills. Funded by @AgEInves & @CienciaGob. #PhD #ScienceJobs. Send Direct Message (DM) on X.

ManelEsteller's tweet image. Join our lab for a 4-year funded PhD in #Epigenomics, #SingleCell, & #SpatialBiology! We’re looking for someone with #Bioinformatics / #Biocomputational skills. Funded by @AgEInves & @CienciaGob. #PhD #ScienceJobs. Send Direct Message (DM) on X.

EllisLab_ reposted

‼️Paper alert‼️ from the ⁦@EllisLab_⁩ seeking data based rationale to treat lethal #ProstateCancer #NEPC EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer biorxiv.org/content/10.110…


EllisLab_ reposted

We congratulate Srinivas Viswanathan, MD, PhD, a 2025 AACR-@KidneyCAN Kidney Cancer Innovation and Discovery Grant recipient. We look forward to his work on TFE3 fusion inhibitors for translocation renal cell carcinoma, a rare kidney cancer with no approved targeted therapies.

AACR's tweet image. We congratulate Srinivas Viswanathan, MD, PhD, a 2025 AACR-@KidneyCAN Kidney Cancer Innovation and Discovery Grant recipient. We look forward to his work on TFE3 fusion inhibitors for translocation renal cell carcinoma, a rare kidney cancer with no approved targeted therapies.

EllisLab_ reposted

Excited to share our CITE-seq atlas of the aging human immune system across tissues. Great collaboration with @DonnaFarber3, @YosefLab, @teichlab, Jo Jones @Cambridge_Uni and partnership with @cziscience! nature.com/articles/s4159…


EllisLab_ reposted

CPDR PIs and Trainees on #TeamProstate enjoyed participating in the classic #GordonResearchConference soccer game of prostate cancer vs breast cancer!

CPDR_Labs's tweet image. CPDR PIs and Trainees on #TeamProstate enjoyed participating in the classic #GordonResearchConference soccer game of prostate cancer vs breast cancer!
CPDR_Labs's tweet image. CPDR PIs and Trainees on #TeamProstate enjoyed participating in the classic #GordonResearchConference soccer game of prostate cancer vs breast cancer!

Congrats ⁦@JasonMuhitch⁩ ⁦@SchwaabieMD⁩ ⁦@DrChoueiri⁩ ⁦@BraunMDPhD⁩ Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma - ScienceDirect sciencedirect.com/science/articl…


🎉🎉👏🏼👏🏼

Very happy and excited to have you in our Division. As Director of the Division welcome Dr @triparnasen! We are looking forward to working together. You join a great team in an amazing institution and in a lead University! @OhioStateMedOnc @OSUCCC_James @OhioStateMed



EllisLab_ reposted

PUBLISHED! The 31st Annual Prostate Cancer Foundation Scientific Retreat Report, which summarizes the cutting-edge research in #ProstateCancer & other fields presented at the 2024 @PCFnews Retreat #PCFRetreat. @soulehoward1 @AndreaMiyahira onlinelibrary.wiley.com/doi/10.1002/pr…

PCF_Science's tweet image. PUBLISHED! The 31st Annual Prostate Cancer Foundation Scientific Retreat Report, which summarizes the cutting-edge research in #ProstateCancer & other fields presented at the 2024 @PCFnews
Retreat #PCFRetreat.  

@soulehoward1
@AndreaMiyahira
onlinelibrary.wiley.com/doi/10.1002/pr…

Time for precision/tailored therapies was yesterday??? 🤔🤔

🚨 #BRCA/#HRR mutations have similar prevalence in low- & high-volume mHSPC, but greater impact in low-volume disease. Doublets (ARPi/docetaxel) yield poor outcomes for BRCA pts. Time for tailored therapies 🤔 annalsofoncology.org/article/S0923-… #OncTwitter #MedTwitter @Annals_Oncology



Loading...

Something went wrong.


Something went wrong.